Langzi, A Fashion Brand For Women'S Wear, Once Again Increased Its Medical Beauty Business By 179 Million Yuan

Recently, Lanzi, a domestic women's wear brand, announced its intention to purchase Sichuan Milan Boyu medical beauty hospital Co., Ltd., Shenzhen Milan Baiyu medical beauty clinic, Sichuan Jingfu medical beauty hospital Co., Ltd., Xi'an Jingfu Medical Beauty Co., Ltd., and Changsha Furong district Jingfu Medical Beauty Co., Ltd. with its own funds of 178.8 million yuan And Chongqing Jingfu medical cosmetology Co., Ltd., and the remaining 30% equity of the six holding subsidiaries. After the completion of the acquisition, Longzi medical will hold 100% equity of the above six companies.

As for the acquisition measures, Lanzi said that the acquisition is another important measure to accelerate the implementation of the company's medical beauty business development strategy, which is conducive to further promoting the company's "Pan fashion industry interconnection ecosystem" strategy, further improving the company's performance scale and long-term operation ability, and thickening the company's performance.

It is understood that in the past three years, the compound growth rate of revenue and net profit of medical beauty business was 70.32% and 115.22% respectively, which benefited from the continuous growth of medical beauty institutions, the continuous expansion of business scale and the continuous increase of the company's investment in medical beauty business.

Among them, the whole medical industry has a broad prospect in China. According to the report, from 2012 to 2019, the scale of domestic medical cosmetology market has been increasing year by year, with a compound annual growth rate of 29%. Last year, the scale of domestic medical beauty market was 11.7 billion yuan, up 22.2% year on year.

At present, it has been committed to the development of international cosmetology, cosmetology, cosmetology, cosmetology, cosmetology, cosmetology, cosmetology and Cosmetology.

In today's situation is not good and clothing competition is big, landsie stock to increase the medical beauty business is undoubtedly a correct move. According to the evening of July 14, Landsea released the revised announcement of its half year performance forecast in 2020, and it is expected that the net profit loss in the first half of the year will be 3-6 million yuan.

Langzi said in the announcement that in the second quarter of 2020, the company's women's clothing business increased its online marketing efforts and reduced its offline terminal sales, and at the same time fully restored the medical and beauty business, making the overall revenue and gross profit rate of the second quarter better than expected, and the company's short-term losses affected by the epidemic situation were eased.

Wu Shaobo, an expert in the garment industry, once said that it is an indisputable fact that the overall growth of the clothing industry has slowed down. The popularity of the medical and beauty industry in recent years has not decreased and there is room for growth. The increase of investment in medical beauty business by Landsat shares is also considered for the overall performance of the company.

It is reported that landside officially entered the medical beauty service business in 2016, and by the end of last year, it had set up 13 medical and aesthetic institutions in China. The long-term planning and consideration of Landsat shares, which seeks to develop in multiple ways and directions, has long-term planning and consideration. In today's era, it may be a good thing to pursue development in multiple directions.